Bristol-Myers (BMY) Shares Volatile Amid Report of Subpoena Related to FCPA Probe
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Join SI Premium – FREE
Bristol-Myers (NYSE: BMY) shares are swinging violently over the last few minutes as Bloomberg is reporting the company received a subpoena in March related to an FCPA investigation.
The stock initially dipped sharply, however is now at an afternoon high. Shares are down 0.6 percent to $34.07.
The stock initially dipped sharply, however is now at an afternoon high. Shares are down 0.6 percent to $34.07.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- FDA grants accelerated approval to Bristol Myers Squibb's Zenbexus
- Nelson Peltz Prepares Bid For Wendy’s - FT
Create E-mail Alert Related Categories
Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
